Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia

Fig. 3

Kaplan–Meier curve analysis of seven expression signatures from GMI with LinkedOmics for the overall survival in AML patients. The median score for each gene signature is displayed in the panel label. Patients with above-median (red, label 1) and below-median (blue, label 0) scores have different overall survival rates. Horizontal axis stands for overall survival time, while vertical axis stands for overall survival probability. P values of less than 0.05 were considered to be statistically significant. A Kaplan-Meier curve of overall survival is derived for (a) ATXN1, (b) CDK6, (c) ABLIM1, (d) IGF2BP2, (e) IGF2R, (f) PLXNC1 and (g) hsa-mir-107 respectively

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us